Integrated Wealth Concepts’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,931
Closed -$916K 1792
2024
Q4
$916K Sell
13,931
-1,162
-8% -$80K 0.01% 858
2024
Q3
$1.07M Sell
15,093
-10
-0.1% -$697 0.01% 777
2024
Q2
$1M Buy
15,103
+1,290
+9% +$84.5K 0.01% 759
2024
Q1
$938K Sell
13,813
-56
-0.4% -$3.7K 0.01% 779
2023
Q4
$857K Buy
13,869
+270
+2% +$15.9K 0.01% 793
2023
Q3
$802K Sell
13,599
-162
-1% -$9.94K 0.01% 780
2023
Q2
$821K Sell
13,761
-1,587
-10% -$94.3K 0.01% 758
2023
Q1
$897K Sell
15,348
-60
-0.4% -$3.61K 0.02% 653
2022
Q4
$956K Buy
15,408
+675
+5% +$40.6K 0.03% 485
2022
Q3
$833K Buy
14,733
+435
+3% +$26.8K 0.03% 462
2022
Q2
$913K Sell
14,298
-660
-4% -$41.9K 0.03% 443
2022
Q1
$968K Buy
14,958
+447
+3% +$28.3K 0.03% 402
2021
Q4
$966K Buy
14,511
+603
+4% +$38.2K 0.03% 429
2021
Q3
$849K Buy
+13,908
New +$884K 0.03% 440

Other funds holding IHE